Cargando…

Sigma-1 receptor and seizures

Over the last decade, sigma-1 receptor (Sig1R) has been recognized as a valid target for the treatment of seizure disorders and seizure-related comorbidities. Clinical trials with Sig1R ligands are underway testing therapies for the treatment of drug-resistant seizures, developmental and epileptic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Vavers, Edijs, Zvejniece, Liga, Dambrova, Maija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176040/
https://www.ncbi.nlm.nih.gov/pubmed/37068533
http://dx.doi.org/10.1016/j.phrs.2023.106771